Back to Search Start Over

Late Clinical Outcomes of Balloon-Expandable Valves in Small Annuli: Results From the PARTNER Trials.

Authors :
Hahn, Rebecca T.
Pibarot, Philippe
Abbas, Amr
Makkar, Raj
Thourani, Vinod H.
Généreux, Philippe
Kodali, Susheel
Kapadia, Samir
Babaliaros, Vasilis
Ternacle, Julien
Theron, Alexis
Cristell, Nicole
Clarke, Sarah
Zhao, Yanglu
Alu, Maria
Madhavan, Mahesh V.
Cohen, David J.
Leipsic, Jonathon
Webb, John
Mack, Michael J.
Source :
JACC: Cardiovascular Interventions; Feb2025, Vol. 18 Issue 4, p506-517, 12p
Publication Year :
2025

Abstract

Short-term clinical outcomes after transcatheter aortic valve replacement (TAVR) are similar in individuals with small or large annuli. The longer term impact of prosthesis-patient mismatch (PPM) and mean gradient (MG) post-TAVR in these patients remains controversial. The aim of this study was to investigate 5-year outcomes in patients with small vs large annuli. Patients from the PARTNER (Placement of Aortic Transcatheter Valves) 2 SAPIEN 3 intermediate-risk registry and the PARTNER 3 low-risk randomized controlled trial were grouped according to small (≤430 mm<superscript>2</superscript>) or large (>430 mm<superscript>2</superscript>) annular size. The primary endpoint was a composite of all-cause death, disabling stroke, or heart failure hospitalization. In addition, the relationships between both PPM and post-TAVR MG and clinical outcomes were analyzed. In total, 1,355 patients were included: 476 with small annuli (376.7 ± 41.9 mm<superscript>2</superscript>) and 879 with large annuli (518.3 ± 58.0 mm<superscript>2</superscript>). Patients with small annuli were older (age 79.6 ± 7.1 years vs 78.7 ± 7.8 years; P = 0.047), were more often female (75.0% vs 16.2%; P < 0.0001), had higher baseline Society of Thoracic Surgeons scores (4.3% ± 1.93% vs 4.0% ± 1.93%; P < 0.0001), and had higher left ventricular ejection fractions (66.3% ± 15.82% vs 59.7% ± 13.68%; P < 0.0001). Primary endpoint rates were similar at 1 year (7.8% vs 8.0%; P = 0.94) and 5 years (36.3% vs 35.8%; P = 0.83). Bioprosthetic valve failure was infrequent at 5 years in both groups (2.9% vs 2.1%; P = 0.46). Among female patients, outcomes were similar for small vs large annuli (primary endpoint; 33.6% vs 34.2%; P = 0.90). Among patients with small annuli, there was no association between 5-year outcomes and any severity of PPM (P = 0.22) or 30-day MG (P for nonlinearity = 0.96). Five-year clinical outcomes were excellent and comparable between patients with small vs large aortic annuli. Outcomes in patients with small annuli were not affected by 30-day MG or PPM. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19368798
Volume :
18
Issue :
4
Database :
Supplemental Index
Journal :
JACC: Cardiovascular Interventions
Publication Type :
Academic Journal
Accession number :
183036028
Full Text :
https://doi.org/10.1016/j.jcin.2024.11.006